TTP can be congenital, resulting from ADAMTS-13 gene mutations, or more commonly acquired as immune-mediated TTP (iTTP), where autoantibodies inhibit ADAMTS-13 activity. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.